AI In Silico Multi-Omics Technique Cuts Therapeutic Development Costs

GATC Health says that an AI-driven in silico multi-omics approach shaves time off preclinical development by derisking programs early-on and expanding opportunities.

The post AI <i>In Silico</i> Multi-Omics Technique Cuts Therapeutic Development Costs appeared first on GEN - Genetic Engineering and Biotechnology News.